Women in Science, Robotics, Automation, SLAS, and Lilly Updates
About this episode
The episode discusses Women in Science Day, advancements in robotics and AI in biological research, and updates on Eli Lilly and Nektar Therapeutics.
Women in Science Day (February 11) was the top of the list for discussion for GEN editors in this week’s podcast. They shared an anecdote on the history of the term “scientist”—hint it was coined for a woman. A modern scientist, Medra CEO Michelle Lee, discussed with GEN how the company is integrating robotics with AI for use in biological research. GEN attended SLAS this week and we got an update on the automation updates along with endeavors to increase the presence of women in biotech leadership. Finally, we get an update on Eli Lilly’s recent major deals followed by an update on Nektar Therapeutics clinical trial updates. Join GEN editors Corinna Singleman, PhD, Fay Lin, PhD, Uduak Thomas and Alex Philippidis for a discussion of the latest biotech and biopharma news. Listed below are links to the GEN stories referenced in this episode of Touching Base : Data Is a Robotics Problem, Medra CEO Says Physical AI Will Transform Biology By Fay Lin, PhD, GEN Edge , February 11, 2026 Robots on the Red Line: A Video Update from SLAS 2026 GEN , February 11, 2026 SLAS Highlights: AI Labs, Small-Molecule SPR, Protein Interaction Assays, and Paper…
More episodes of Touching Base
- AI in Oncology Takes Off, Tackling HIV and Liver Disease, Pharma’s Recent Gains
- Drugs from a Text Prompt, Wegovy Pill Competition Dampens Lilly’s Surge
- Agentic AI, Virtual Cell, LNP Vaccine Boosters, Engineered Organs, and Mergers
- Bacteria 4D Simulation, Safer Large Gene Insertion, uniQure Roller Coaster
- AI for Scientists, FDA Reverses Course, and Advances in Cancer Therapeutics
- Ex-CEO Behind Bars, 10x’s Clinical Ambitions, and Pharma’s AI Gambit
Explore listener stats, chart rankings, contacts and more on the Touching Base podcast page.